103 related articles for article (PubMed ID: 1879038)
1. [Advance in drug treatment of primary and familial hypercholesterolemia].
Liu K
Zhong Xi Yi Jie He Za Zhi; 1991 May; 11(5):315-7. PubMed ID: 1879038
[No Abstract] [Full Text] [Related]
2. [Study of LDL receptors and response to lovastatin therapy in familial homozygotic hypercholesterolemia].
Ausina Gómez A; Gilsanz Peral A; Montero Brens C; Dalmau Serra J
An Esp Pediatr; 1991 Nov; 35(5):327-31. PubMed ID: 1785747
[TBL] [Abstract][Full Text] [Related]
3. [Homozygous familial hypercholesterolemia. Response to combined cholestyramine and lovastatin therapy].
Obando Santaella I; Fernández Gómez E; Mongil Ruiz I; Escobar Gallego A; García Alegría JJ; Gascón Luna F; Masana Marín L
An Esp Pediatr; 1990 Jul; 33(1):58-60. PubMed ID: 2252289
[TBL] [Abstract][Full Text] [Related]
4. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
Stein E; Kreisberg R; Miller V; Mantell G; Washington L; Shapiro DR
Arch Intern Med; 1990 Feb; 150(2):341-5. PubMed ID: 2405804
[TBL] [Abstract][Full Text] [Related]
5. Contrasting effects of lovastatin and cholestyramine on low-density lipoprotein cholesterol and 24-hour urinary mevalonate excretion in patients with heterozygous familial hypercholesterolemia.
Pappu AS; Illingworth DR
J Lab Clin Med; 1989 Nov; 114(5):554-62. PubMed ID: 2809398
[TBL] [Abstract][Full Text] [Related]
6. Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs.
Illingworth DR; Bacon S
Arteriosclerosis; 1989; 9(1 Suppl):I121-34. PubMed ID: 2492189
[TBL] [Abstract][Full Text] [Related]
7. Lovastatin: cholesterol-lowering agent.
DiPalma JR
Am Fam Physician; 1987 Dec; 36(6):189-92. PubMed ID: 3687679
[No Abstract] [Full Text] [Related]
8. Combined drug therapy--cholestyramine and compactin--for familial hypercholesterolemia.
Yamamoto A; Yamamura T; Yokoyama S; Sudo H; Matsuzawa Y
Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):493-7. PubMed ID: 6500769
[TBL] [Abstract][Full Text] [Related]
9. Probucol in patients resistant to the lipid-lowering effects of cholestyramine.
Mann JI; Jelfs R; Cassels E; Barker K; Simpson HC; Carter RC
Lancet; 1981 Feb; 1(8217):450. PubMed ID: 6110087
[No Abstract] [Full Text] [Related]
10. [Evaluation of the addition of fenofibrate to the simvastatin-cholestyramine combination].
Schlienger JL
Presse Med; 1991 Mar; 20(12):565. PubMed ID: 1827899
[No Abstract] [Full Text] [Related]
11. Lovastatin vs cholestyramine therapy for primary hypercholesterolemia.
JAMA; 1988 Dec 23-30; 260(24):3590-1. PubMed ID: 3193586
[No Abstract] [Full Text] [Related]
12. [Familial hypercholesterolemia--intensive diet therapy combined with drug therapy].
Stugaard M; Wiig I; Lund H; Ose L; Norseth J
Tidsskr Nor Laegeforen; 1992 Aug; 112(20):2642-6. PubMed ID: 1412289
[TBL] [Abstract][Full Text] [Related]
13. Comparison of six pharmacologic regimens for hypercholesterolemia.
Hoeg JM; Maher MB; Bailey KR; Brewer HB
Am J Cardiol; 1987 Apr; 59(8):812-5. PubMed ID: 3644588
[TBL] [Abstract][Full Text] [Related]
14. A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia. The Lovastatin Study Group III.
JAMA; 1988 Jul; 260(3):359-66. PubMed ID: 2898027
[TBL] [Abstract][Full Text] [Related]
15. Repetitive intermittent flow plasma exchange in patients with severe hypercholesterolemia.
Stein EA; Glueck CJ; Wesselman A; Owens ER; Nichols S; Vink P
Atherosclerosis; 1981; 38(1-2):149-64. PubMed ID: 7470196
[No Abstract] [Full Text] [Related]
16. Sterol synthesis in vitro in freshly isolated blood mononuclear leukocytes from familial hypercholesterolemic patients treated with probucol.
McNamara DJ; Bloch CA; Botha A; Mendelsohn D
Biochim Biophys Acta; 1985 Mar; 833(3):412-6. PubMed ID: 3970963
[TBL] [Abstract][Full Text] [Related]
17. Long-term treatment of a homozygous cholesteryl ester storage disease with combined cholestyramine and lovastatin.
Yokoyama S; McCoy E
J Inherit Metab Dis; 1992; 15(2):291-2. PubMed ID: 1528002
[No Abstract] [Full Text] [Related]
18. Probucol and cholestyramine combination in the treatment of severe hypercholesterolemia.
Sommariva D; Bonfiglioli D; Tirrito M; Pogliaghi I; Branchi A; Cabrini E
Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):505-10. PubMed ID: 3781686
[TBL] [Abstract][Full Text] [Related]
19. [Experimental and clinical study of Vasosan P, a new form of pectin-enriched cholestyramine].
Ryzhenkov VE; Chistiakova AM; Triufanov VF; Vasil'eva LE; Frolova IuV; Solov'eva MA; Remezova OV; Lozovskiĭ VT; Khanefel'd M; Leonkhardt V
Kardiologiia; 1990 Aug; 30(8):77-9. PubMed ID: 2255152
[TBL] [Abstract][Full Text] [Related]
20. Treatment of hypercholesterolemia.
Kane JP; Malloy MJ
Med Clin North Am; 1982 Mar; 66(2):537-50. PubMed ID: 7040850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
